Introducing Venlafaxine Hydrochloride Tablets by PharmAlliance International Labs Private Limited

Welcome to PharmAlliance International Labs, where we prioritize your mental well-being and strive to provide innovative pharmaceutical solutions to improve your quality of life. Our Venlafaxine Hydrochloride Tablets represent a breakthrough in the treatment of mood disorders, underscoring our dedication to enhancing patient health and happiness.

Drug Class:

Venlafaxine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI), distinguishing itself by its dual mechanism of action. By selectively inhibiting the reuptake of serotonin and norepinephrine in the brain, venlafaxine effectively modulates neurotransmitter levels, offering relief from symptoms of depression and anxiety.

Formulations:

PharmAlliance International Labs offers Venlafaxine Hydrochloride Tablets in two strengths: 37.5mg tablets (packed in 20’s) and 50mg tablets (packed in 20’s). Designed for oral administration, our tablets provide convenience and efficacy for patients seeking relief from mood disorders.

Indications:

Our Venlafaxine Hydrochloride Tablets are indicated for the treatment of:

Major Depressive Disorder (MDD): Addressing the debilitating symptoms associated with MDD, including persistent feelings of sadness, loss of interest or pleasure, and cognitive impairments.

Generalized Anxiety Disorder (GAD): Alleviating the distressing symptoms of GAD, such as excessive worry, restlessness, and irritability.

Usage:

For optimal therapeutic outcomes, Venlafaxine Hydrochloride Tablets should be taken orally, with or without food, as directed by your healthcare provider. Adherence to the prescribed treatment regimen and dosage instructions is paramount to achieving symptom relief and enhancing overall well-being.

Dosage:

The recommended starting dose for MDD is 75mg per day, administered either in divided doses or as a single daily dose. Patients with GAD typically initiate treatment with 37.5mg per day, with dosage adjustments tailored to individual response and tolerability.

Pharmacokinetics:

Upon oral administration, venlafaxine is rapidly absorbed, reaching peak plasma concentrations within 2 to 3 hours. Metabolized extensively by hepatic enzymes, including CYP2D6 and CYP3A4, venlafaxine and its active metabolites exhibit an elimination half-life of 5 to 11 hours, facilitating once- or twice-daily dosing schedules.

Pharmacodynamics:

The therapeutic efficacy of venlafaxine stems from its ability to enhance serotonin and norepinephrine neurotransmission in the synaptic cleft. By modulating these key neurotransmitters, venlafaxine effectively regulates mood, alleviating symptoms of depression and anxiety disorders.

Side Effects:

While generally well-tolerated, Venlafaxine Hydrochloride Tablets may elicit common side effects such as nausea, headache, dizziness, dry mouth, and insomnia. Some individuals may experience changes in blood pressure, sweating, or sexual dysfunction. Serious side effects, including serotonin syndrome or suicidal ideation, are rare but necessitate immediate medical attention.

Place your trust in the efficacy and safety of Venlafaxine Hydrochloride Tablets from PharmAlliance International Labs Private Limited. We are committed to providing compassionate care and innovative solutions for mental health disorders, empowering you to lead a fulfilling life. For additional information, please visit our website or consult with your healthcare provider. Your well-being is our priority.